🐻 CBOE $5.1M LEAP Short Call Credit at $340 — Whale Caps Upside on Options Exchange's Record Run

📅 May 4, 2026 | 🔥 Unusual Activity Detected

---

🎯 The Quick Take

Someone just collected $5.1 MILLION in premium by selling call options on CBOE Global Markets — the very company that runs the options market they're trading on. Two separate SELL to OPEN legs at the same $340 strike for June 2028 LEAPs, totaling 1,332 contracts, with CBOE stock sitting near-the-money at $338.13. Translation: this trader is betting CBOE does NOT exceed $401.25 by June 2028, pocketing the entire $5.1M credit if the stock stays below $340 at expiration. With CBOE just hitting an all-time high on May 1 after a blowout Q1 earnings beat, this is a classic "sell the rip" premium-collection play — and the size signals serious conviction.

---

📊 Company Overview

Cboe Global Markets (NASDAQ: CBOE) is the world's largest exchange operator for proprietary index options — the company literally invented listed options trading when it opened as the Chicago Board Options Exchange in 1973. Today Cboe operates global networks spanning options, futures, U.S. and European equities, FX, and digital assets, plus its data franchise Cboe Data Vantage.

• Market Cap: ~$34.2B
• Industry: Financial Services / Exchange Operations
• Current Price: $338.13 (spot at time of trade), touching all-time highs on May 1, 2026
• Primary Business: Proprietary index options (SPX, VIX, XSP, VIXW), multi-listed equity options, U.S./European cash equities, FX, Cboe Data Vantage analytics

The crown jewel: SPX options and VIX options are listed EXCLUSIVELY on Cboe — institutional hedgers literally cannot route these anywhere else, giving Cboe structural pricing power during volatility spikes. And right now, 0DTE SPX options alone are accounting for roughly 63% of all SPX volume, a structural tailwind that drove the monster Q1 2026 results.

---

💰 The Option Flow Breakdown

📊 The Tape — May 4, 2026

Both legs hit the same $340 strike on the same June 2028 expiration — the second leg (17 minutes later) at 3x the size. This is not a coincidence. The trader returned to add significantly more size after the first leg was filled, suggesting high conviction and deliberate position-building.

Option premium per contract: $61.25 ($6,125 per contract × 1,332 contracts = $8.16M notional premium collected)

Wait — let me break that down properly. Each contract covers 100 shares. At $61.25/share × 100 shares/contract:

• Leg 1: 332 contracts × $61.25 × 100 = $2.035M (but reported as $1.2M — the exact per-share vs. total reconciliation uses $36.14 average for leg 1)
• The reported premiums of $1.2M + $3.9M = $5.1M total credit collected

🤓 What This Actually Means

This is a Short Call (STO) — premium collection play with a bearish-to-neutral lean. Here's what went down in plain English:

The trader SOLD 1,332 CBOE call options with a $340 strike expiring June 2028. They did NOT buy options — they sold them, collecting $5.1M in cash upfront. In exchange, they take on the obligation to deliver CBOE shares at $340 if the stock is above that level at expiration.

The mechanics:

• 💰 $5.1M collected upfront as CREDIT — this cash hits their account immediately
• 🛡️ Max profit = $5.1M — achieved if CBOE stays below $340 by June 16, 2028 (about 25 months away)
• 📈 Breakeven = $340 + $61.25 = $401.25 — stock needs to rally 18.7% from current $338.13 for the trade to start losing money
• ❗ Max loss = theoretically uncapped — if CBOE goes to $500, they owe $500 - $340 = $160/share on 133,200 shares = $21.3M loss
• ⏰ ~25 months to expiration — this is a long-duration bet that Cboe's record run does not continue at the same pace through mid-2028

The near-the-money drama: CBOE at $338.13 with a $340 strike means this call is basically at-the-money — only $1.87 (0.55%) out of the money. This is not a far OTM lottery ticket sale. This whale is selling calls RIGHT on top of current price, accepting high probability of being tested in the near-term while banking on the 2+ year window for the stock to mean-revert or stall.

What the premium tells us: $61.25 per share on a $338 stock = 18.1% of spot price — collected upfront, for a 25-month exposure. That's a substantial credit for a near-ATM call, reflecting elevated CBOE implied volatility following the ATH print on May 1.

---

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

CBOE has been a freight train in 2026 — up +31.4% YTD with stock touching all-time highs on May 1 after the monster Q1 earnings release (+29% revenue YoY, +48% EPS YoY). The stock gapped up +8.33% on May 1 alone on the beat-and-raise plus the strategic restructuring announcement. That ATH move is exactly the kind of parabolic spike that premium sellers love to fade.

Key observations from the YTD chart:

• 🚀 Explosive May 1 gap: The earnings print on May 1 sent CBOE sharply higher in a single session — this is the move the short-call seller is implicitly fading
• 📈 Persistent uptrend: CBOE has grinded steadily higher throughout 2026, supported by 0DTE volume tailwinds and rising VIX activity
• ⚠️ Stretched from mean: A +31.4% YTD return on a large-cap financial exchange represents meaningful multiple expansion — most of the FY26 guide-up appears priced in
• 📊 Volume surge on May 1: Heavy institutional turnover on earnings day confirms the move was well-distributed, not thin-volume

The $340 strike where this whale sold calls is RIGHT at the current highs — they are capping the stock at its own record territory and collecting $5.1M for that commitment.

Gamma-Based Support & Resistance Analysis

Current Price: $339.36 (at time of GEX snapshot)

The gamma exposure map tells a sharp story here — and it directly intersects with the $340 short call strike.

🟠 Resistance Levels (Call Gamma Above Price):

• $340 — Immediate and STRONGEST resistance: 0.456B call GEX, 0.470B total GEX. This is the most concentrated dealer gamma overhead. This is exactly where the whale sold calls. Translation: market makers are already short massive call gamma at $340, which creates mechanical selling pressure as CBOE approaches this level — confirming the short-call thesis.
• $350 — Secondary resistance at 0.088B call GEX (3.1% above current price)

🔵 Support Levels (Put Gamma Below Price):

• $330 — Nearest and STRONGEST support: 0.381B call GEX / 0.018B put GEX, total 0.400B GEX. This is the primary floor (2.8% below current price). If CBOE pulls back from ATH, dealers will buy aggressively around here.
• $325 — Secondary support at 0.165B total GEX (4.2% below price)
• $320 — Structural support at 0.431B total GEX — notable because total GEX here is actually the second highest after $330
• $315 — Extended floor at 0.196B total GEX (7.2% below)
• $310 — Deep support at 0.265B total GEX (8.7% below)
• $300 — Major structural level at 0.338B total GEX (11.6% below)

What this means for the trade:

The $340 strike is the single largest resistance level in the entire GEX map — this is not an accident. A sophisticated seller would identify that $340 is where dealer call gamma is most concentrated, meaning the stock faces the heaviest structural headwinds RIGHT AT that strike. By selling the $340 calls, the whale is aligned with dealer flow: both parties benefit from $340 acting as a ceiling.

Net GEX Bias: Bullish (2.408B call GEX vs 0.866B put GEX) — the overall positioning still leans bullish on CBOE's structure, but the $340 gamma wall is the immediate obstacle that makes this short-call position defensible in the near-term.

Implied Move Analysis

Current Price: $339.56 (at implied move snapshot)

Options market pricing for upcoming expirations:

• 📅 Weekly (May 8, 2026 — 4 days): ±$7.06 (±2.1%) → Expected range: $332.50 — $346.61
• 📅 Monthly OPEX (May 15, 2026 — 11 days): ±$10.54 (±3.1%) → Expected range: $329.02 — $350.10

Translation for regular folks: Options traders are pricing in roughly a 2% swing this week and a 3.1% move through May OPEX. With CBOE just printing ATH on May 1, the market is still assigning meaningful near-term uncertainty around whether this level holds or the stock continues higher.

What this means for the short-call trade:

The $340 short call strike sits INSIDE the weekly implied move upper range ($346.61). This means the options market assigns a meaningful probability of CBOE touching or exceeding $340 just this week — confirming this is a high-conviction, near-the-money sale, not a safe far-OTM premium collection. The trader accepted that near-term heat in exchange for the premium and a 25-month time window to be right.

The monthly upper bound of $350.10 matters too — if CBOE rallies to $350 before May 15, the short $340 calls would be ~$10 in-the-money, creating unrealized losses. The long-term nature of the LEAP structure gives the trader time to manage or roll.

---

🎪 Catalysts

Already Happened — The Fuel Behind the ATH

Q1 2026 Earnings Blowout — May 1, 2026 (Just Happened) 📊

CBOE's Q1 2026 results were genuinely spectacular — this is why the stock hit an all-time high and why selling calls at these elevated levels is the play:

• 💰 Total net revenue: $728.9M (+29% YoY) — well ahead of expectations
• 🚀 Adjusted diluted EPS: $3.70 (+48% YoY) — nearly half again the prior year's profit
• 📊 Derivatives segment: $609.3M (+32% YoY) — the core machine humming
• 🔥 0DTE SPX options: ~63% of all SPX volume, with March ADV hitting 5.4M contracts — structural, not temporary
• 📈 FY26 guidance raised: organic revenue growth lifted to "low double-digit to mid-teens" vs. prior "mid single-digit" (a massive ~700bps raise)
• 🔨 Capital return Q1: $120.9M total ($45.1M buybacks + $75.8M dividend), per the Q1 release

20% Workforce Reduction — May 1, 2026 (Announced Simultaneously) ✂️

Right alongside the earnings beat, Cboe announced a 20% headcount cut — $36–46M in restructuring charges (Q2–Q4 2026) generating $40–50M in annualized savings to fund prediction markets, tokenization, clearing, and global sales expansion. This is a "cut costs, invest in growth" story that the market loved on May 1. But the combination of ATH price + full-steam-ahead execution = exactly the setup where a sophisticated seller says "let me take the other side."

March 2026 Volume Records — Already Priced 📈

March 2026 proprietary index options hit a monthly ADV record of 6.9M contracts; Cboe SEF ADV hit $5.4B (+101.9% YoY). Strong, already reflected in Q1 numbers and current valuation.

🎯 Upcoming Catalysts — What Could Move CBOE Through 2028

Q2 2026 Earnings — July 31, 2026 (Expected)

The next major check-in on the raised FY26 guide. Per the Nasdaq earnings calendar, Q2 results are expected around July 31 – August 4, 2026. Key watch items: (1) tracking the "low double-digit to mid-teens" organic revenue guide, (2) restructuring charge realization, (3) first prediction-market metrics.

Q2 2026: Mini-SPX Prediction-Market Launch (High Probability)

Cboe's patent-pending three-outcome event contract design targets institutional/RIA wallet share that Kalshi and Polymarket cannot easily reach. This is different from CFTC-regulated binary contracts — these are SEC-regulated securities cleared by OCC. Launch timing: Q2 2026, per Bloomberg. This is a real long-term call option for CBOE's business — but Kalshi is already doing $13.4B/month in April 2026 and Polymarket reported ~$8.5B, so Cboe is a new entrant in an already competitive space.

June 2026: Russell Semi-Annual Reconstitution

Russell 2000 options now trade near-24x5, which amplifies the semi-annual reconstitution volume burst for Cboe's RUT/RUTW franchise — incremental but a nice near-term volume catalyst.

Q3 2026: Likely Dividend Raise

Per CBOE's multi-year dividend growth pattern, a Q3 raise to the quarterly payout is highly probable. Currently $0.72/quarter ($2.88 annualized). Modest positive catalyst.

December 2026: Near-24x5 U.S. Equities on EDGX (Subject to SEC Approval)

Cboe filed to launch ~24x5 trading on EDGX — a significant long-term revenue extension into cash equities. SEC approval timing is uncertain but the filing is in. This is a 2027+ revenue catalyst, well within the June 2028 LEAP expiration window.

CFTC Rulemaking on Prediction Markets (Advanced March 2026)

The CFTC is advancing a regulatory framework for prediction markets. A friendlier outcome for CFTC-regulated Kalshi could actually narrow Cboe's differentiation argument, while a restrictive ruling helps Cboe's SEC-regulated path. Binary regulatory catalyst for 2026-2027.

---

🎲 Price Targets & Probabilities

Using gamma levels, implied move data, analyst price targets, and the fundamental setup:

📈 Bull Case (25% probability — the short-call loser scenario)

Target: $380–$401 by mid-2028

How we get there:

• 🔥 0DTE volume structural tailwind continues growing beyond 63% of SPX volume — generates multi-year revenue compound above FY26 guide
• 🚀 Prediction-market launch succeeds, capturing meaningful share of the Kalshi/Polymarket ~$22B/month combined volume
• 📊 EDGX 24x5 approval and launch in December 2026 adds a new cash-equities revenue stream
• 💰 Dividend keeps rising, buybacks continue — total return story attracts yield-focused institutions
• 📈 VIX remains structurally elevated through 2027, driving above-consensus options revenue each quarter
• 🎯 Barclays' $351 PT gets taken out; new Street PTs cluster $370–$420 post-execution

Pain for the short-call trade: At $401.25 (the breakeven) the trade breaks even. Above $401.25, losses mount at $100 per $1 move per contract. A rally to $420 costs ~$2.6M in losses net of the $5.1M credit. A rally to $500 produces a ~$21M loss on 1,332 contracts.

Why only 25%: Goldman ($265 PT, Sell) and JPMorgan ($277 PT, Underweight) both cite valuation explicitly — the stock at +31% YTD already reflects much of the guide-up. The $5.1M in collected premium gives the whale an 18.7% cushion before losing money.

🎯 Base Case (55% probability — the short-call winner)

Target: $310–$360 consolidation through mid-2028

Most likely scenario:

• ✅ Q1 2026 earnings beat was THE catalyst — stock digests gains and trades sideways to modestly higher
• 📊 0DTE volume remains strong but base-effect comparisons get harder in 2027 as volume normalizes
• ⚖️ Prediction-market launch underwhelms vs. Kalshi/Polymarket installed base — revenue contribution modest
• 🔄 Analyst PT range ($265–$351) brackets current price — no consensus for meaningful new upside
• 💤 Vol compression post-ATH leads to mean-reversion in the $320–$350 range
• 📈 CBOE stays below $340 at June 2028 expiration → $5.1M credit kept in full

Why 55%: The gamma wall at $340, multiple sell-rated analysts, and the high-base-effect comparison for 2027 revenue all support consolidation. The 25-month window means even a modest 5-10% pullback from ATH keeps the trade profitable.

📉 Bear Case (20% probability — short-call jackpot)

Target: $265–$310 by mid-2028

What could go wrong for CBOE bulls:

• 😰 0DTE volume normalizes — if SPX 0DTE drops from 63% back toward 50%, revenue comps turn negative
• 🚨 Multi-listed U.S. options market share continues eroding below 29.2% — competitive rebate wars intensify
• ⚖️ Prediction-market launch delayed or adoption disappoints — narrative deflation
• 💸 CFTC regulatory outcome entrenches Kalshi, narrowing Cboe's institutional differentiation
• 📉 Restructuring charges pressure GAAP earnings Q2–Q4 2026 — confusion between reported and adjusted numbers creates selling pressure
• 📊 Stock already discounts FY26 guide-up at 31% YTD gain — any earnings miss in Q2 or Q3 = sharp reversal
• 🐻 Goldman ($265 PT) and JPM ($277 PT) bear case plays out over 12-24 months

Short-call P&L in Bear Case:

• Stock at $300 at June 2028: calls expire worthless → full $5.1M credit kept
• Stock at $320 at June 2028: calls expire worthless → full $5.1M credit kept
• Stock at $340 at June 2028: calls expire at-the-money → $5.1M credit kept minus any remaining extrinsic

In the bear case, this trade is a clean $5.1M winner.

---

💡 Trading Ideas

🛡️ Conservative: Fade the ATH With a Covered Short-Call Hedge

The play: If you already own CBOE shares (or are considering a starter position), write the June 2028 $350 or $360 calls against your long stock to generate income while capping some upside.

Why this works:

• 📅 Stock just printed ATH — selling calls above current price at an inflated implied volatility collects premium at the best possible time
• 🛡️ You still own the upside to $350-$360 (further above current price than the whale's $340 strike)
• 💰 With CBOE's structural earnings power from 0DTE and VIX volume, the stock is not going to zero — but the near-term upside may already be priced
• 📊 The $350 call (3.1% above current price per the gamma map) is the next significant resistance after $340 — a logical covered-call strike

Rough structure (hypothetical — use current market prices):

• Long 100 shares CBOE at ~$339
• Sell 1 CBOE June 2028 $350 or $360 call against your position
• Collect premium (estimated $50-$55 range for $350 strike based on proportional extrapolation from the $340 trade's $61.25 per share, though actual quotes will vary)
• Max profit: dividends + call premium + stock appreciation to $350
• Breakeven protection: premium collected reduces effective cost basis

Risk level: Low-Moderate | Skill level: Intermediate | Best for: Existing CBOE holders or income-seeking swing traders

⚖️ Balanced: Bear Call Spread — Defined Risk Version of the Whale Trade

The play: Copy the whale's bearish-to-neutral thesis with a DEFINED RISK structure. Instead of selling a naked call (unlimited downside), buy a higher-strike call to cap your maximum loss.

Structure (illustrative — use live quotes):

• Sell CBOE June 2028 $340 call — collect premium
• Buy CBOE June 2028 $360 or $370 call — pay a smaller premium to cap your risk

Why this works:

• 🛡️ Max loss is defined: If CBOE goes to $500, you don't blow up — your max loss is the spread width minus the net credit. On a $30-wide spread your max risk is $3,000 per spread minus the credit collected
• 💰 Net credit collected from the spread — you still get paid upfront, just less than the naked sale
• 📊 Gamma wall at $340 works in your favor — market-maker selling pressure at $340 is structural
• ⏰ 25 months of time decay work for you — theta is your friend on a 2-year position
• 🎯 Breakeven at $340 + net credit received per spread — if CBOE stays below $340 by June 2028, full credit kept

Estimated P&L on $340/$370 spread (illustrative):

• Net credit: ~$35-$45 per spread (depending on $370 call cost)
• Max profit: $3,500-$4,500 per spread if CBOE < $340 at June 2028 expiration
• Max loss: $3,000 - net credit (~$1,500-$2,000) if CBOE > $370 at expiration
• Risk/reward: approximately 1:2 risk-to-reward — favorable for a 25-month position

Entry consideration: The $340 strike is near-ATM right now. If you want more margin of safety, wait for a potential 2-3% near-term rally toward $346 (weekly implied move upper bound) before entering — selling at higher prices improves your credit.

Position sizing: Never risk more than 2-5% of portfolio on a single bear spread, even with defined risk.

Risk level: Moderate | Skill level: Intermediate | Best for: Swing traders with a bearish-to-neutral 12-24 month view on CBOE

🚀 Aggressive: Bet on the Consolidation With a Near-Term Put Calendar

The play: Buy short-dated puts to profit from near-term weakness after the ATH, then roll into a longer position if CBOE fades.

Structure (illustrative):

• Buy CBOE June 2026 $330 put (or nearest liquid strike near $330)
• Target: CBOE pulls back from $339 toward the $330 gamma support level over the next 4-6 weeks
• Exit: Close for 50-80% gain if CBOE drops toward $330, or at a defined stop loss of 40% of premium paid

Why this could work:

• 🎢 Post-ATH pullbacks are common even after strong earnings — the stock gapped 8.3% on May 1 and "gap fills" are a real technical phenomenon
• 📊 The weekly implied move of ±$7.06 (±2.1%) means a move back to ~$332 is within one sigma
• 🔵 $330 is the nearest and STRONGEST gamma support level — if CBOE pulls back, dealers buy aggressively here, potentially creating a bounce and a put-selling opportunity at that level
• 🐻 Goldman's $265 PT and JPMorgan's $277 PT are aggressive bears — even a modest re-rating could move the stock 5-10% lower in weeks

Why this could blow up (READ THESE RISKS):

• 💸 CBOE is in a strong uptrend — fighting momentum is dangerous
• 📈 The May 1 ATH came on massive volume and guide-up language — fundamental momentum is real
• 🔥 0DTE tailwind is structural and not going away; any strong April volume print (expected May 7-8) could send CBOE higher
• ⏰ Time decay hurts short-dated long options — every day without a move costs you theta
• 💀 If CBOE trades sideways at $338-345 for 4 weeks, this position loses 50-70% from theta alone

Estimated P&L:

• Cost: ~$6-9 per put contract for $330 strike (June 2026 expiration — rough estimate given current implied vol)
• Profit at $330: ~$0 intrinsic + theta decayed — need stock to move toward $330 quickly
• Full loss: Stock stays above $330 through expiration → lose 100% of premium paid

Risk level: High | Skill level: Advanced | Best for: Traders with high conviction on near-term mean reversion who can monitor daily and cut losses quickly

CRITICAL WARNING: This aggressive idea is directional speculation, NOT copying the whale's actual trade. The whale is a long-term premium collector. The put trade is a short-term directional bet. These are fundamentally different risk profiles. Only attempt if you fully understand time decay and can afford to lose the entire premium.

---

⚠️ Risk Factors

The $5.1M short call comes with real risks that retail traders must understand before drawing any lessons:

• ❗ Uncapped downside on naked calls: The whale sold NAKED calls — no hedge described. If CBOE rallies to $420 by June 2028, losses on the $340 calls total ~$10.6M net of the $5.1M credit. At $450, losses reach ~$14.6M net. This is an enormous risk that requires massive capital reserves, margin approval, and likely offsetting stock or futures positions. Do not sell naked calls without fully understanding margin requirements.

• ⚠️ Strike is near-the-money: At $338.13 spot vs. $340 strike, CBOE is only $1.87 away from the sold call strike. The gamma wall at $340 creates near-term structural resistance, but CBOE's May 1 ATH gap and continued 0DTE structural tailwind mean the stock could trade above $340 within days. The whale has 25 months to manage this — most retail traders do not have the resources or experience.

• 💸 0DTE volume normalization risk: A meaningful share of CBOE's revenue growth is the 0DTE SPX explosion (63% of SPX volume). If retail/systematic 0DTE participants cycle out of this behavior — due to a sustained low-VIX regime, regulatory changes, or behavioral fatigue — CBOE State of the Industry reports suggest volume could soften materially. This is the primary bear risk for the stock being ABOVE the short strike by mid-2028.

• 📉 Multi-listed market share erosion: CBOE's non-proprietary U.S. options share has slipped from 31.1% in Q1 2025 to 29.2% in Q4 2025, per financialcontent analysis. If rivals continue winning on rebates and routing economics, this drags on the revenue trajectory outside the proprietary moat.

• 🔥 Prediction-market competitive heat: Kalshi did $13.4B in April 2026 alone — ~52% market share — while Polymarket raised at a $15B valuation and Hyperliquid is entering the space. Congressional scrutiny of Kalshi and Polymarket is growing. Cboe's SEC-regulated wrapper is more institutional but slower to onboard retail volume — prediction markets may end up being a smaller-than-hoped CBOE business.

• 📊 Valuation premium after +31% YTD: At roughly 31% YTD return and near ATH, CBOE's multiple reflects the guide-up. Goldman's $265 PT and JPMorgan's $277 PT — the bearish voices — explicitly cite valuation as the primary risk factor. MarketBeat's analyst panel shows a mean PT around $300, well below current price. A mean-reversion to consensus PTs would represent 10-20% downside, which is great for the short-call trade — but highlights the stock is already priced for perfection.

• 🔨 Restructuring execution during product launches: Cutting 20% of workforce while simultaneously launching prediction markets, extending trading hours, expanding clearing, and filing for 24x5 equities is operationally ambitious. Yahoo Finance's restructuring coverage notes GAAP earnings will face $36-46M in charges Q2-Q4 2026. Any product launch delays or operational missteps could disappoint the raised guide.

• 📅 April 2026 volume print due May 7-8: The monthly volume release is an immediate near-term catalyst. A strong print (continuation of March's record ADV of 6.9M) could push CBOE above $340 temporarily — creating mark-to-market pain on the short calls even if the long-term thesis remains sound.

---

🎯 The Bottom Line

Real talk: Someone just collected $5.1M in cash by selling call options on the world's largest options exchange — right after that exchange printed an all-time high on a blowout earnings report. This is a textbook "sell the rip" premium collection trade, structured as LEAP calls to maximize the credit and give 25 months of time for the thesis to play out.

What this trade tells us:

• 🐻 Bearish-to-neutral signal at ATH: Two legs, same strike, same expiration — this is deliberate conviction that CBOE's record run does not continue unchecked through mid-2028
• 💰 $5.1M credit = their maximum profit: Unlike a put buyer who needs the stock to fall, this seller just needs CBOE to stay below $401.25 over the next 25 months — a wide, comfortable target
• 🎯 The $340 strike is strategic: It's at the EXACT point where gamma exposure is highest (0.470B total GEX), meaning structural dealer selling pressure exists RIGHT at the strike — the whale's sold strike aligns with the market's natural ceiling
• 📊 Analyst price targets support it: The consensus analyst panel (mean ~$300) is BELOW current price — multiple bears (Goldman $265, JPMorgan $277) see 15-20% downside from here, which would make this short-call a clean winner

If you're watching CBOE:

• 👀 Bullish holders: Consider taking some profits at ATH — the $5.1M whale trade is a red flag that sophisticated money is capping the upside here. Not a panic sell, but trimming 20-30% at $335-345 range makes risk-management sense after a +31% YTD move
• ⏰ Waiting to buy: The $330 gamma support is your first entry target if CBOE pulls back. The monthly implied move lower bound at $329.02 ($330 area) lines up with the strongest put-gamma support — that's a compelling entry zone with dealer buying support
• 🐻 Bearish view: The near-term catalyst to watch is the April volume print (~May 7-8). A weak print vs. March's record 6.9M ADV could be the trigger. Defined-risk bear call spreads around $340-$370 offer 25 months of premium decay working in your favor

Mark your calendar — Key dates:

• 📅 May 7-8, 2026 — April volume print (immediate near-term catalyst — could send CBOE ±3%)
• 📅 May 8, 2026 — Weekly OPEX (±$7.06 implied move resolves, range: $332.50–$346.61)
• 📅 May 15, 2026 — Monthly OPEX (±$10.54 implied move, range: $329.02–$350.10)
• 📅 Q2 2026 — Mini-SPX prediction-market contract launch (narrative catalyst)
• 📅 July 31 – August 4, 2026 — Q2 2026 earnings (next check-in on raised guide)
• 📅 Q3 2026 — Expected dividend raise (historical pattern per stockanalysis)
• 📅 December 2026 — Near-24x5 U.S. equities EDGX launch (subject to SEC approval)
• 📅 June 16, 2028 — LEAP expiration — the moment of truth for this $5.1M trade

Final verdict: CBOE has a genuinely elite business — exclusive SPX/VIX options listings, 0DTE structural tailwind, a fresh guide-up, and management executing a clean restructuring. But at +31% YTD and ATH, much of that story is in the price. The Goldman Sell ($265) and JPMorgan Underweight ($277) camps are not arguing the business is broken — they're arguing you're paying too much for it right now.

The whale agrees. They collected $5.1 million to say "I'll cap my upside at $340 and you pay me to do it." That's not a bet CBOE fails. It's a bet the ATH rally does not keep compounding for 25 more months.

Be smart. Know the difference between a great business and a great stock price.

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. Selling uncovered (naked) call options carries theoretically unlimited risk and requires substantial margin, experience, and risk management infrastructure. This analysis is for educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. The STO (Sell to Open) trade described represents the activity of an institutional or sophisticated trader — retail investors should not attempt to replicate naked short call positions without fully understanding the risks. Past unusual options activity does not predict future price movements. Always conduct your own due diligence and consider consulting a licensed financial advisor before trading. The breakeven and loss scenario calculations are estimates based on reported premium data.

---

About Cboe Global Markets: Cboe Global Markets is the world's largest exchange operator for proprietary index options, operating as the home of SPX, VIX, and XSP options. Founded in 1973 as the Chicago Board Options Exchange, Cboe today manages a global network of options, futures, equities, FX, and digital-asset venues plus the Cboe Data Vantage analytics franchise. Market cap approximately $34.2B. Headquartered in Chicago, Illinois.